Tuesday, May 18 from 7AM-10:30AM EST | Friday, May 21 from 8AM-11:30AM EST | Tuesday, May 25 from 8AM-11:30AM EST
The global response to COVID-19 has pushed the boundaries on what is possible for rapid pandemic response in several areas, including advancing vaccine research and development, bolstering vaccine distribution and supply chains, reinforcing non-vaccine public health interventions and countermeasures, and encouraging global coordination, partnerships and financing. Furthermore, the global COVID-19 response has provided new data around the efficacy and best practices surrounding pandemic planning and response.
This global public workshop will convene international experts, thought-leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.
Agenda:
Keynote: Supply Chain Challenges during COVID-19 in Africa
- John Nkengasong | Director, Africa Centres for Disease Control
Panel 1: Upstream Supply Challenges and their Downstream Implications
- Julie Swann, Moderator | Department Head, Fitts Department of Industrial and Systems Engineering, North Carolina State University
- Matthew Downham | Sustainable Manufacturing Lead, Coalition for Epidemic Preparedness Innovation (CEPI)
- Rasmus Bech Hansen | CEO, Airfinity
- Daniel Rodriguez | Director, Procurement and Supply Management, PAHO
Panel 2: Improving Last Mile Delivery of Medical Products
- Ben Adeiza Adinoyi, Moderator | Head, Health and Care Unit, Africa Region, International Federation of Red Cross and Red Crescent Societies
- Rodrigo Cruz | Executive Secretary, Ministry of Health, Brazil
- Patrick Tippoo | Head, Science and Innovation, Biovac; Executive Director, African Vaccine Manufacturing Initiative
- Marie Mazur | Managing Director, Ready2Respond
Breakout sessions
Breakout 1: Data Sharing for Improved Situational Awareness
- Paula Barbosa, Moderator | Associate Director, Vaccines Policy, International Federation of Pharmaceutical Manufacturers and Associations
- Rob Handfield | Executive Director, Supply Chain Resource Cooperative; Professor of Supply Chain Management, North Carolina State University
- Rasmus Bech Hansen | CEO, Airfinity
- Julie Swann | Department Head, Fitts Department of Industrial and Systems Engineering, North Carolina State University
Breakout 2: Financing and Investment
- Christopher Snyder, Moderator | Professor, Economics, University of Dartmouth
- Erin Sparrow | Technical Officer, Vaccine Product and Delivery Research, WHO
- Nagwa Hasanin | Senior Advisor for Health, Supply Division, UNICEF
- Tapiwa Mukwashi | Director, Supply Chain, Village Reach
- Amos Zaindi | Malawi Country Director, CARE
Breakout 3: Equity in Supply Chain
- David Kaslow, Moderator | Chief Scientific Officer, PATH
- Mark McKinlay | Director, Center for Vaccine Equity, The Task Force for Global Health
- Phionah Atuhebwe | Vaccines Introduction Medical Officer, WHO-AFRO
- Ben Adeiza Adinoyi | Head, Health and Care Unit, Africa Region, International Federation of Red Cross and Red Crescent Societies
The workshop will feature invited presentations and discussions to:
- Highlight late-breaking developments in vaccine R&D or manufacturing that can inform future pandemic influenza planning.
- Explore current global coordination frameworks and opportunities for future pandemic planning, including funding mobilization, technology transfer, and surveillance and data sharing.
- Discuss lessons learned from COVID-19 vaccine rollout and delivery, as well as public health countermeasures sourcing, including inventory unpredictability and cascading effects of shortages of critical inputs and ancillary materials.
- Explore gaps in One Health governance, global surveillance, and risk assessment.
- Highlight equity challenges in the “last mile” of medical product delivery, and needs identified in order to improve future planning and deployment of products.
- Explore innovations in surveillance and data sharing during COVID-19 and other epidemics that can be adapted and scaled for future influenza events.
- Discuss best practices for communicating emerging research and building public confidence in vaccines and public health measures.
The deliberations of this workshop will also inform the four study committees related to this project: (1) Vaccine research and development, including platforms in discovery and manufacturing, (2) Vaccine distribution and supply chain, (3) Non-vaccine public health interventions and countermeasures, and (4) International coordination, innovative partnerships, and sustainable financing for influenza preparedness and response.
